Non-Linear Mixed Effects Modeling ??? From Methodology and Software Development to Driving Implementation in Drug Development Science, Journal of Pharmacokinetics and Pharmacodynamics, vol.72, issue.6, pp.161-83, 2005. ,
DOI : 10.1007/s10928-005-0062-y
NONMEM User's guides, Icon development Solutions, 1989. ,
Experimental design and efficient parameter estimation in population pharmacokinetics, Journal of Pharmacokinetics and Biopharmaceutics, vol.46, issue.4, pp.347-60, 1990. ,
DOI : 10.1007/BF01062273
Simulation of Clinical Trials, Annual Review of Pharmacology and Toxicology, vol.40, issue.1, pp.209-243, 2000. ,
DOI : 10.1146/annurev.pharmtox.40.1.209
Optimum Experimental Design, 1992. ,
DOI : 10.1007/978-3-642-04898-2_434
The Logic of Inductive Inference, Journal of the Royal Statistical Society, vol.98, issue.1, pp.39-54, 1935. ,
DOI : 10.2307/2342435
Optimal design in random-effects regression models, Biometrika, vol.84, issue.2, pp.429-471, 1997. ,
DOI : 10.1093/biomet/84.2.429
Fisher information matrix for non-linear mixed-effects models: evaluation and application for optimal design of enoxaparin population pharmacokinetics, Statistics in Medicine, vol.26, issue.6, pp.2623-2662, 2002. ,
DOI : 10.1002/sim.1041
Design evaluation and optimisation in multiple response nonlinear mixed effect models: PFIM 3.0, Computer Methods and Programs in Biomedicine, vol.98, issue.1, pp.55-65, 2010. ,
DOI : 10.1016/j.cmpb.2009.09.012
URL : https://hal.archives-ouvertes.fr/inserm-00431457
PopED: An extended, parallelized, nonlinear mixed effects models optimal design tool, Computer Methods and Programs in Biomedicine, vol.108, issue.2, pp.789-805, 2012. ,
DOI : 10.1016/j.cmpb.2012.05.005
A program for individual and population optimal design for univariate and multivariate response pharmacokinetic-pharmacodynamic models Adaptive optimal design for bridging studies with an application to population pharmacokinetic studies, Comput Methods Prog Biomed. Pharm Res, vol.8629, issue.16, pp.51-61, 2007. ,
Methods of Robust Design of Nonlinear Models with an Application to Pharmacokinetics, Journal of Biopharmaceutical Statistics, vol.253, issue.4, pp.886-902, 2010. ,
DOI : 10.1080/10543400600851880
Optimization of Individual and Population Designs Using Splus, Journal of Pharmacokinetics and Pharmacodynamics, vol.30, issue.6, pp.417-460, 2003. ,
DOI : 10.1023/B:JOPA.0000013000.59346.9a
Bayesian design criteria: Computation, comparison, and application to a pharmacokinetic and a pharmacodynamic model, Journal of Pharmacokinetics and Biopharmaceutics, vol.19, issue.1, pp.101-126, 1995. ,
DOI : 10.1007/BF02353788
Forecasting individual pharmacokinetics, Clinical Pharmacology & Therapeutics, vol.26, issue.3, pp.294-305, 1979. ,
DOI : 10.1002/cpt1979263294
Bayesian Individualization of Pharmacokinetics: Simple Implementation and Comparison with Non-Bayesian Methods, Journal of Pharmaceutical Sciences, vol.71, issue.12, pp.1344-1352, 1982. ,
DOI : 10.1002/jps.2600711209
Mixed models: design of experiments. Presented at Design and analysis of experiments, 2011. ,
Importance of Shrinkage in Empirical Bayes Estimates for Diagnostics: Problems and Solutions, The AAPS Journal, vol.11, issue.3, pp.558-69, 2009. ,
DOI : 10.1208/s12248-009-9133-0
Sparse-Sampling Optimal Designs in Pharmacokinetics and Toxicokinetics, Therapeutic Innovation & Regulatory Science, vol.29, issue.3, pp.997-1019, 1995. ,
DOI : 10.1177/009286159502900321
Population Pharmacokinetic Analysis of Tocilizumab in Patients With Rheumatoid Arthritis, The Journal of Clinical Pharmacology, vol.47, issue.suppl II, pp.754-66, 2010. ,
DOI : 10.1177/0091270009350623
Linear Mixed Models for Longitudinal Data, 2000. ,
DOI : 10.1007/978-1-4612-2294-1_3
Bayesian estimation and experimental design in linear regression models. Leipzig: Teubner-Texte, 1983. ,
NONMEM users guide ? Part V introductory guide. Ellicott City: Icon development Solutions, 2011. ,
Compound Optimal Design Criteria for Nonlinear Models, Journal of Biopharmaceutical Statistics, vol.48, issue.2, pp.646-61, 2008. ,
DOI : 10.1080/10543400802071352
Constructing optimal designs for fitting pharmacokinetic models, Statistics and Computing, vol.9, issue.3, pp.209-227, 1999. ,
DOI : 10.1023/A:1008922030873
Design of cross-over trials for pharmacokinetic studies, Journal of Statistical Planning and Inference, vol.78, issue.1-2, pp.307-323, 1999. ,
DOI : 10.1016/S0378-3758(98)00221-3